ArticleBMC pediatrics2026
Acute myeloid leukemia following treatment of malignant rhabdoid tumor of the kidney: a case report.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMalignant rhabdoid tumor of the kidney (MRTK) is a rare and highly aggressive pediatric malignancy with a poor prognosis. We report a rare case of acute myeloid leukemia (AML) developing after successful treatment of MRTK in a child and discuss its clinical course and possible therapy-related etiology. CASE PRESENTATION: We successfully treated a 12-year-old Iranian girl of Turkish ethnicity with stage III or higher MRTK in Qazvin, Iran, using surgery, chemotherapy, and radiotherapy. Approximately 7 months after completion of chemotherapy and radiotherapy, and 16 months after the initial diagnosis of MRTK, the patient developed acute myeloid leukemia.
conclusionThis case highlights the development of acute myeloid leukemia after treatment for malignant rhabdoid tumor of the kidney in a pediatric patient. Long-term follow-up is essential for the early detection of secondary malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.